Progyny, Inc. (NASDAQ:PGNY) Receives $23.64 Consensus PT from Analysts

by · The Markets Daily

Progyny, Inc. (NASDAQ:PGNY – Get Free Report) has been given an average recommendation of “Hold” by the thirteen brokerages that are covering the company, Marketbeat.com reports. Eight equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $23.64.

Several brokerages recently commented on PGNY. JPMorgan Chase & Co. boosted their price target on shares of Progyny from $17.00 to $23.00 and gave the stock a “neutral” rating in a report on Tuesday, January 28th. Bank of America boosted their target price on shares of Progyny from $21.00 to $25.00 and gave the stock a “buy” rating in a research note on Tuesday, February 11th. Canaccord Genuity Group raised their price target on shares of Progyny from $17.00 to $23.00 and gave the company a “hold” rating in a research note on Friday, February 28th. Finally, BTIG Research upgraded Progyny from a “neutral” rating to a “buy” rating and set a $28.00 price objective on the stock in a report on Monday, March 31st.

Get Our Latest Stock Report on Progyny

Progyny Trading Up 0.2 %

Shares of PGNY opened at $21.44 on Monday. The firm has a market cap of $1.84 billion, a P/E ratio of 36.97, a PEG ratio of 2.39 and a beta of 1.33. The stock’s 50 day moving average is $21.94 and its two-hundred day moving average is $18.84. Progyny has a 12 month low of $13.39 and a 12 month high of $33.84.

Institutional Investors Weigh In On Progyny

Large investors have recently made changes to their positions in the stock. River Road Asset Management LLC purchased a new position in Progyny during the fourth quarter worth approximately $25,529,000. Pacer Advisors Inc. raised its holdings in shares of Progyny by 47.5% during the 4th quarter. Pacer Advisors Inc. now owns 3,676,200 shares of the company’s stock worth $63,414,000 after acquiring an additional 1,183,558 shares during the period. Fort Washington Investment Advisors Inc. OH grew its holdings in shares of Progyny by 90.1% in the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 1,467,780 shares of the company’s stock valued at $25,319,000 after purchasing an additional 695,740 shares during the period. Barclays PLC increased its position in Progyny by 95.7% during the fourth quarter. Barclays PLC now owns 1,382,205 shares of the company’s stock worth $23,843,000 after purchasing an additional 676,048 shares during the last quarter. Finally, D. E. Shaw & Co. Inc. purchased a new position in Progyny during the fourth quarter worth about $11,265,000. 94.93% of the stock is currently owned by hedge funds and other institutional investors.

Progyny Company Profile

(Get Free Report

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.

Read More